PCM
TNL icon

Patient Capital Management’s Travel + Leisure Co TNL Stock Holding History

Patient Capital Management’s Portfolio TNL Stock Details TNL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-116,599
Closed -$5.88M – 44
2024
Q4 		$5.88M Sell
116,599
-767,534
-87% -$38.9M 0.27% 34
2024
Q3 		$40.7M Sell
884,133
-15,742
-2% -$695K 2% 27
2024
Q2 		$40.5M Sell
899,875
-89,550
-9% -$4.02M 2.15% 24
2024
Q1 		$48.4M Sell
989,425
-132,862
-12% -$5.67M 2.36% 19
2023
Q4 		$43.9M Sell
1,122,287
-130,049
-10% -$4.72M 2.32% 19
2023
Q3 		$46M Sell
1,252,336
-7,071
-0.6% -$282K 2.7% 16
2023
Q2 		$50.8M Buy
1,259,407
+1,132,107
+889% +$43.6M 2.83% 15
2023
Q1 		$4.99M Hold
127,300
– – 2.22% 22
2022
Q4 		$4.63M Buy
127,300
+10,100
+9% +$378K 2.25% 22
2022
Q3 		$4M Buy
117,200
+22,850
+24% +$966K 2% 24
2022
Q2 		$3.66M Buy
94,350
+46,700
+98% +$2.3M 1.62% 29
2022
Q1 		$2.76M Sell
47,650
-7,750
-14% -$437K 0.94% 36
2021
Q4 		$3.06M Buy
+55,400
New +$2.96M 0.88% 38

Other funds holding TNL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
CapitalatWork SA Auderghem $3.99B AUM 29.18% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Patient Capital Management's TNL Position: Q1 2025 in Review

Patient Capital Management sold out of Travel + Leisure Co (TNL) in Q1 2025, closing a stake of 116,599 shares — an estimated $5.88M sold.

Patient Capital Management first reported a position in TNL in Q4 2021 and held it in 13 quarters. The position peaked at $50.8M in Q2 2023. 400 funds tracked by Wall St. Rank hold TNL as of Q1 2025.

  • Patient Capital Management reported no remaining Travel + Leisure Co position as of Q1 2025 after selling out during the quarter.
  • Patient Capital Management sold 116,599 Travel + Leisure Co shares in Q1 2025, an estimated $5.88M.
  • Patient Capital Management first reported a position in Travel + Leisure Co in Q4 2021 and held it in 13 quarters.
  • Patient Capital Management's Travel + Leisure Co position peaked at $50.8M in Q2 2023.
  • 400 funds tracked by Wall St. Rank held Travel + Leisure Co as of Q1 2025.

Based on Patient Capital Management's 13F filing for Q1 2025, filed 14 May 2025.